The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Experimental allergic encephalomyelitis: A misleading model of multiple sclerosis
Abstract
Despite many years of intensive research, multiple sclerosis (MS) defies understanding and treatment remains suboptimal. The prevailing hypothesis is that MS is immune mediated and that experimental allergic encephalomyelitis (EAE) is a suitable model to elucidate pathogenesis and devise therapy. This review examines critically the validity that EAE is an adequate and useful animal model of MS and finds credible evidence lacking. EAE represents more a model of acute central nervous system inflammation than the counterpart of MS. We propose to reconsider the utilization of EAE, especially when this model is used to define therapy. This will also force us to examine MS without the restraints imposed by EAE, as to what it is, rather than what it looks like. Ann Neurol 2005;58:939–945
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Itskovitz-Eldor, J., Schuldiner, M., Karsenti, D., Eden, A., Yanuka, O., Amit, M., Soreq, H., & Benvenisty, N. (2000) · Molecular Medicine · doi:10.1007/bf03401776 · Cited by 1,500
Binder (2004) · doi:10.1080/08977190410001723308 · Cited by 1,481
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,185
Exacerbations of multiple sclerosis in patients treated with gamma interferon
Panitch, H., Haley, A., Hirsch, R., & Johnson, K. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92863-7 · Cited by 1,071
The T Lymphocyte In Experimental Allergic Encephalomyelitis
Zamvil, S. (1990) · Annual Review of Immunology · doi:10.1146/annurev.immunol.8.1.579 · Cited by 1,009
Ferber, I. A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D., & Fathman, C. G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.5 · Cited by 989
Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M., Schröder, R., Deckert, M., Schmidt, S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.393 · Cited by 951
T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis
Ota, K., Matsui, M., Milford, E. L., Mackin, G. A., Weiner, H. L., & Hafler, D. A. (1990) · Nature · doi:10.1038/346183a0 · Cited by 912
Bielekova, B., Goodwin, B., Richert, N., Cortese, I., Kondo, T., Afshar, G., Gran, B., Eaton, J., Antel, J., Frank, J. A., et al. (2000) · Nature Medicine · doi:10.1038/80516 · Cited by 823
Panitch, H. S., Hirsch, R. L., Schindler, J., & Johnson, K. P. (1987) · Neurology · doi:10.1212/wnl.37.7.1097 · Cited by 751
A Pathogenic Role for Myelin-Specific Cd8+ T Cells in a Model for Multiple Sclerosis
Huseby, E. S., Liggitt, D., Brabb, T., Schnabel, B., Öhlén, C., & Goverman, J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.669 · Cited by 659
Pettinelli, C. B., & McFarlin, D. E. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.4.1420 · Cited by 588
New concepts in the immunopathogenesis of multiple sclerosis
Hemmer, B., Archelos, J. J., & Hartung, H.-P. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn784 · Cited by 580
Handbook of Clinical Neurology: Diseases of Nerves, Part II
DINAPOLI, R. P. (1972) · Neurology · doi:10.1212/wnl.22.4.394 · Cited by 577
Bjartmar, C., Wujek, J. R., & Trapp, B. D. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00069-2 · Cited by 573
Lafaille, J. J., Nagashima, K., Katsuki, M., & Tonegawa, S. (1994) · Cell · doi:10.1016/0092-8674(94)90419-7 · Cited by 532
Kappos, L., Comi, G., Panitch, H., Oger, J., Antel, J., Conlon, P., Steinman, L., Comi, G., Kappos, L., Oger, J., et al. (2000) · Nature Medicine · doi:10.1038/80525 · Cited by 512
Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases
Neumann, H. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02154-9 · Cited by 480
Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration
Bø, L., Vedeler, C. A., Nyland, H., Trapp, B. D., & Mørk, S. J. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms917oa · Cited by 478
Myelin Antigen-Specific CD8+ T Cells Are Encephalitogenic and Produce Severe Disease in C57BL/6 Mice
Sun, D., Whitaker, J. N., Huang, Z., Liu, D., Coleclough, C., Wekerle, H., & Raine, C. S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7579 · Cited by 444
ENCEPHALOMYELITIS ACCOMPANIED BY MYELIN DESTRUCTION EXPERIMENTALLY PRODUCED IN MONKEYS
Rivers, T. M., & Schwentker, F. F. (1935) · Journal of Experimental Medicine · doi:10.1084/jem.61.5.689 · Cited by 435
Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic Lesions
Traugott, U., Reinherz, E. L., & Raine, C. S. (1983) · Science · doi:10.1126/science.6217550 · Cited by 421
Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions
Hauser, S. L., Bhan, A. K., Gilles, F., Kemp, M., Kerr, C., & Weiner, H. L. (1986) · Annals of Neurology · doi:10.1002/ana.410190610 · Cited by 399
Skulina, C., Schmidt, S., Dornmair, K., Babbe, H., Roers, A., Rajewsky, K., Wekerle, H., Hohlfeld, R., & Goebels, N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308689100 · Cited by 348
Late Complications of Immune Deviation Therapy in a Nonhuman Primate
Genain, C. P., Abel, K., Belmar, N., Villinger, F., Rosenberg, D. P., Linington, C., Raine, C. S., & Hauser, S. L. (1996) · Science · doi:10.1126/science.274.5295.2054 · Cited by 320
Traugott, U., Reinherz, E. L., & Raine, C. S. (1983) · Journal of Neuroimmunology · doi:10.1016/0165-5728(83)90036-x · Cited by 315
Booss, J., Esiri, M. M., Tourtellotte, W. W., & Mason, D. Y. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90201-0 · Cited by 294
Animal models for autoimmune demyelinating disorders of the nervous system
Gold, R., Hartung, H.-P., & Toyka, K. V. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01639-1 · Cited by 292
Natarajan, C., & Bright, J. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6506 · Cited by 288
The Dale E. McFarlin memorial lecture: The immunology of the multiple sclerosis lesion
Raine, C. S. (1994) · Annals of Neurology · doi:10.1002/ana.410360716 · Cited by 285
Ziemssen, T. (2002) · Brain · doi:10.1093/brain/awf252 · Cited by 268
van Oosten, B. W., Lai, M., Hodgkinson, S., Barkhof, F., Miller, D. H., Moseley, I. F., Thompson, A. J., Rudge, P., McDougall, A., McLeod, J. G., et al. (1997) · Neurology · doi:10.1212/wnl.49.2.351 · Cited by 264
Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients
Jacobsen, M., Cepok, S., Quak, E., Happel, M., Gaber, R., Ziegler, A., Schock, S., Oertel, W. H., Sommer, N., & Hemmer, B. (2002) · Brain · doi:10.1093/brain/awf059 · Cited by 253
Assessment of Animal Models for MS and Demyelinating Disease in the Design of Rational Therapy
Steinman, L. (1999) · Neuron · doi:10.1016/s0896-6273(00)81107-1 · Cited by 245
Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis
Cepok, S. (2001) · Brain · doi:10.1093/brain/124.11.2169 · Cited by 242
Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis
Fernando, K. T. M. (2004) · Brain · doi:10.1093/brain/awh153 · Cited by 222
Ebers, G. C. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530240016003 · Cited by 216
The CD4–Th1 model for multiple sclerosis: a crucial re-appraisal
Lassmann, H., & Ransohoff, R. M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.01.007 · Cited by 203
Kojima, K., Berger, T., Lassmann, H., Hinze-Selch, D., Zhang, Y., Gehrmann, J., Reske, K., Wekerle, H., & Linington, C. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.817 · Cited by 188
Therapeutic Approaches in Multiple Sclerosis: Lessons from Failed and Interrupted Treatment Trials
Wiendl, H., & Hohlfeld, R. (2002) · BioDrugs · doi:10.2165/00063030-200216030-00003 · Cited by 183
The immunogenesis of the multiple sclerosis plaque
Lumsden, C. E. (1971) · Brain Research · doi:10.1016/0006-8993(71)90052-7 · Cited by 170
Genetic models for CNS inflammation
Owens, T., Wekerle, H., & Antel, J. (2001) · Nature Medicine · doi:10.1038/84603 · Cited by 164
The Immunology of Multiple Sclerosis and its Animal Model, Experimental Allergic Encephalomyelitis
Owens, T., & Sriram, S. (1995) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30061-6 · Cited by 160
Self-citationAxonal degeneration and progressive neurologic disability in multiple sclerosis
Bjartmar, C., & Trapp, B. D. (2003) · Neurotoxicity Research · doi:10.1007/bf03033380 · Cited by 154
Candidate autoantigens in multiple sclerosis
Schmidt, S. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500303 · Cited by 91
Role of MRI in multiple sclerosis I: inflammation and lesions
Zivadinov, R., & Bakshi, R. (2004) · Frontiers in bioscience · doi:10.2741/1251 · Cited by 90
Therapy with glatiramer acetate for multiple sclerosis
Munari, L., Lovati, R., & Boiko, A. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004678 · Cited by 89
Delayed, relapsing experimental allergic encephalomyelitis in mice.
LUBLIN, F. D., Maurer, P. H., Berry, R. G., & Tippett, D. S. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.3.819 · Cited by 87
Ranjeva, J., Pelletier, J., Sylviane Confort-gouny, A., Ibarrola, D., Audoin, B., Fur, Y. L., Viout, P., Chérif, A. A., & Cozzone, P. J. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms938oa · Cited by 63
Pathogenesis of multiple sclerosis: The eyes only see what the mind is prepared to comprehend
Trapp, B. D. (2004) · Annals of Neurology · doi:10.1002/ana.20087 · Cited by 59
Jyothi, M. D., Flavell, R. A., & Geiger, T. L. (2002) · Nature Biotechnology · doi:10.1038/nbt758 · Cited by 53
der Aa, A. V. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00048-1 · Cited by 52
Magnetic resonance spectroscopy in multiple sclerosis: window into the diseased brain
Wolinsky, J. S., & Narayana, P. A. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200206000-00004 · Cited by 51
Matthews, P., & Arnold, D. L. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200106000-00004 · Cited by 51
Imaging neuronal and axonal degeneration in multiple sclerosis
de Stefano, N., Guidi, L., Stromillo, M., Bartolozzi, M. L., & Federico, A. (2003) · Neurological Sciences · doi:10.1007/s10072-003-0175-2 · Cited by 50
Lisak, R. P., Zweiman, B., Blanchard, N., & RORKE, L. B. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90205-8 · Cited by 46
Koehler, N. K. U., Genain, C. P., Giesser, B. S., & Hauser, S. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5920 · Cited by 45
Rösener, M., Muraro, P. A., Riethmüller, A., Kalbus, M., Sappler, G., Thompson, R. J., Lichtenfels, R., Sommer, N., McFarland, H. F., & Martinꝉ, R. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00230-5 · Cited by 32
Experimental immunotherapies for multiple sclerosis
Martinꝉ, R., & McFarland, H. F. (1996) · Springer Seminars in Immunopathology · doi:10.1007/bf00792605 · Cited by 29
Remitting-relapsing EAE in nonhuman primates: A valid model of multiple sclerosis
Rose, L. M., Richards, T. L., Petersen, R., Peterson, J. R., Hruby, S., & Alvord, E. C. (1991) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(91)90077-n · Cited by 16
Immunotherapy of Inflammatory Demyelinating Diseases of the Central Nervous System
Bright, J. J., & Sriram, S. (2001) · Immunologic Research · doi:10.1385/ir:23:2-3:245 · Cited by 11
Self-citationDiagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cited by
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
Constantinescu, C. S., Farooqi, N., O'Brien, K., & Gran, B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01302.x · Cited by 1,523
Myelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 728
Active induction of experimental allergic encephalomyelitis
Stromnes, I. M., & Goverman, J. M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.285 · Cited by 573
The impact of microglial activation on blood-brain barrier in brain diseases
da Fonseca, A. C. C., Matias, D., Garcia, C., Amaral, R., Geraldo, L. H., Freitas, C., & Lima, F. R. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00362 · Cited by 572
“…Murine Encephalomyelitis Virus-Induced Demyelinating Disease (TMEV-IDD; Rodriguez et al., 1987) and experimental autoimmune encephalomyelitis (EAE), where activation of microglia precedes infiltration of peripheral macrophages and occurs before the onset of the disease (Sriram and Steiner, 2005).”
BackgroundSegal, B. M., Constantinescu, C. S., Raychaudhuri, A., Kim, L., Fidelus-Gort, R., & Kasper, L. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70173-x · Cited by 479
Metadata
- Authors
- Sriram, S., & Steiner, I.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2005-11-28
- Volume
- 58
- Issue
- 6
- Pages
- 939-945
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2167896409
- Cited by
- 264
- References
- 65
- FWCI
- 11.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.